Page last updated: 2024-12-05

2-phenylpyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-phenylpyridine is a heterocyclic organic compound with the formula C11H9N. It is a white solid that is commonly used as a ligand in coordination chemistry. The compound is synthesized by the reaction of pyridine with phenyllithium. 2-phenylpyridine is an important ligand in various fields, such as catalysis, materials science, and medicinal chemistry. It is frequently used in the preparation of transition metal complexes that exhibit catalytic activity. 2-phenylpyridine complexes are also known to exhibit luminescent properties and have applications in organic light-emitting diodes (OLEDs). Research into this compound is driven by its versatility as a ligand and its potential applications in various fields.'

2-phenylpyridine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13887
CHEMBL ID1193163
SCHEMBL ID35754
MeSH IDM0162697

Synonyms (38)

Synonym
nsc-89291
nsc89291
AC-5097
unii-2y6s09838q
2y6s09838q ,
einecs 213-763-1
nsc 89291
o-phenylpyridine
pyridine, 2-phenyl-
inchi=1/c11h9n/c1-2-6-10(7-3-1)11-8-4-5-9-12-11/h1-9
1008-89-5
2-phenylpyridine
2-phenylpyridine, 98%
P1039
AKOS005257841
CHEMBL1193163
2-phenyl-pyridine
BP-10684
FT-0601233
AM81313
SCHEMBL35754
phenylpyridine
2-phenyl pyridine
phenyl pyridine
W-108933
mfcd00006280
DTXSID6074417
CS-W007468
mfcd31699954
2-(phenyl-2-d)pyridine
SY246291
372492-47-2
AS-14490
Q18205048
SY017662
O10850
EN300-105801
Z1255464971
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1572601Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 2 days by MTT assay2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes.
AID1149238Dissociation constant, pKa of the compound1976Journal of medicinal chemistry, Apr, Volume: 19, Issue:4
Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
AID1572600Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 2 days by MTT assay2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes.
AID1572602Cytotoxicity against HEK293 cells assessed as decrease in cell viability after 2 days by MTT assay2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes.
AID1572604Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human MCF7 cells2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.77)18.7374
1990's1 (1.89)18.2507
2000's11 (20.75)29.6817
2010's38 (71.70)24.3611
2020's1 (1.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.22 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index55.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]